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Table 1
PCA with varimax rotation for 11 different sites on CE-MRI, component loading*
Anatomical sites of synovitis on CE-MRI Components
1 2 3 4
Adjacent to posterior cruciate ligament site 0.762
Suprapatellar site 0.762
Intercondylar site (at surface of Hoffa's
fat pad)
0.720
Lateral parameniscal site 0.461 0.454
Medial parapatellar site 0.821
Lateral parapatellar site 0.791
Baker Cyst 0.635
Adjacent to the anterior cruciate ligament 0.806
Medial parameniscal site 0.746
Loose Body 0.832
Infra patellar site -0.707
% variance explained 23% 20% 12% 12%
* Note: only loadings >0.4 are displayed
Abstracts / Osteoarthritis and Cartilage 21 (2013) S9–S62S16were frozen or incubated for 24h in serum-free media. Visfatin/NAMPT
conformation and release inmedia by the different tissueswas evaluated
using Western Blot (WB) and ELISA, respectively. In parallel, proteins
were extracted from frozen joint tissues to assess the in situ production
and conformation of visfatin/NAMPT by WB. NAMPT enzymatic activity
was also assessed in OA synovium using Cyclex colorimetric assay.
Primary cultures of mouse chondrocytes and osteoblasts were stimu-
latedwith recombinant visfatin/NAMPT (5 mg/mL) for 24h. To determine
in vitro the role of the NAMPT activity, cells were pretreated or not 4h
before visfatin/NAMPT stimulation with APO866 (10nM), a pharmaco-
logic inhibitor of NAMPT activity (1). Effects of stimulation on IL-6, IL-8/
Kc, MCP-1, VEGF and TGFb expression, and on IL-6, IL-8/Kc and MCP-1
release were examined by quantitative RT-PCR and ELISA, respectively.
Results: All human OA joint tissues released visfatin/NAMPT (syno-
vium: 529 356, cartilage: 237 380, subchondral bone: 195 92 ng/g
tissue) with higher level for the synovium compared to cartilage and
subchondral bone (p<0.01). In tissular explants and conditionnated
media, visfatin/NAMPT was found as a homodimer, corresponding to
the enzymatically active conformation. Moreover, NAMPT activity was
identiﬁed ex vivo in synovium and characterized by a reaction velocity
at 1.38E-3  8E-4 min-1 (n¼3). Visfatin/NAMPT signiﬁcantly induced IL-
6, IL-8/Kc and MCP-1 gene expressions and protein productions by
chondrocytes and osteoblasts (n[6) (Table). Nampt activity inhibi-
tion by APO866 decreased pro-inﬂammatory cytokines expression
atmRNA level (up to 94 % of inhibition) as well as at protein level (up
to 63 % of inhibition) and was especially efﬁcient in chondrocytes
(Table). VEGF and TGFb expression were unchanged upon stimulation,
suggesting that visfatin/NAMPT has selective properties.
Conclusions:Visfatin/NAMPT is releasedbyall OA tissuesunder a dimeric
enzymatically active conformation and mostly by the synovium which
displays a detectable NAMPT activity. The NAMPT activity of visfatin is
involved in chondrocytes and osteoblasts activation, suggesting that tar-
geting its enzymatic activity with a compound like APO866 (being tested
in hematological malignancies) may be a new therapeutic approach.Gene expression Protein production
IL-6 Kc/IL-8 MCP-1 IL-6 Kc/IL-8 MCP-1
Chonodrocytes
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
10.6  3
(p ¼ 0.015)
4.9  1.3
(p ¼ 0.015)
2.5  0.4
(p ¼ 0.03)
5.8  5
(p ¼ 0.016)
29.7  33
(p ¼ 0.015)
10.5  2
(p ¼ 0.016)
Mean % of inhibition by APO866, p-value 94 %
(p ¼ 0.015)
83 %
(p ¼ 0.015)
62 %
(p ¼ 0.015)
63 %
(p ¼ 0.016)
57 %
(p ¼ 0.031)
54 %
(p ¼ 0.016)
Osteoblasts
(n ¼ 6)
Fold induction after visfatin/NAMPT
stimulation (Mean  SEM), p-value
296  59
(p ¼ 0.031)
262  96
(p ¼ 0.016)
161  78
(p ¼ 0.016)
115  46
(p ¼ 0.016)
164  71
(p ¼ 0.016)
22  7
(p ¼ 0.031)
Mean SEM % of inhibition by APO866 63 %
(p ¼ 0.031)
86 %
(p ¼ 0.016)
84 %
(p ¼ 0.047)
31 %
(p ¼ 0.031)
34 %
(p ¼ 0.08)
41 %
(p ¼ 0.06)16
DIFFERENT PATTERNS OF SYNOVITIS AS SEEN ON CE-MRI IN
PATIENTS WITH KNEE OSTEOARTHRITIS
B. de Lange-Brokaar y, A. Ioan-Facsinay y, E. Yusuf y, W. Visser y, H.
Kroon y, G. van Osch z, A.-M. Zuurmond x, V. Stojanovic-Susulic k, J.
Bloem y, R. Nelissen y, T. Huizinga y, M. Kloppenburg y. y LUMC, Leiden,
Netherlands; z Erasmus MC, Rotterdam, Netherlands; x TNO, Leiden,
Netherlands; k Janssen Res. & Dev., LLC, Spring House, PA, USAPurpose: Synovitis is prevalent in knee OA and is an important deter-
minant of pain. To better understand the nature of synovitis and its
association with pain we investigated patterns of synovitis on contrast
enhanced (CE) MRI and its relation to pain.
Methods:43patients (mean (SD)age60(21)years, 63%woman,BMI30(5)
kg/mm2, median (IQR) Kellgren-Lawrence score 3 (2-4)) with symptom-
atic knee OA attending the rheumatology or orthopaedic outpatient clinic
were included. 22 patients underwent arthroscopy and 21 arthroplasty.
Sagittal and axial T1-weighted CE MRI images (3T) were used to semi-
quantitatively score synovitis at 11 sites (total range 0-22) according to
Guermazi et al. (Ann RheumDis 2011). Self-reported painwas assessed by
visual analogue scale (VAS, 0-100), knee injuryand osteoarthritis outcome
score (KOOS (subscale pain),0-100) and measure of intermittent and
constant osteoarthritis pain (ICOAP, intermittent pain (0-100), constant
pain (0-100)). Principal component analysis (PCA) with varimax rotation
and Keiser Normalizationwas used to investigate patterns of synovitis for
all patients. A factor was said to load signiﬁcantly on a component whenloading exceeded 0.4. Subsequently, different patterns were associated
with pain measures in linear regression analysis adjusted for age, sex and
BMI, using SPSS 20.0. Log transformations were used when appropriate.
Results: A mild synovitis was observed (mean (SD) 8.0 (3.7)). Mean (SD)
KOOS pain was 49.6 (23.6) and ICOAP intermittent pain 42.0 (21.8).
Median (IQR) VASwas 57.0 (37-68) and ICOAP constant pain 35.0 (20-55).
PCA resulted in extraction of 4 components (Eigen value > 1), explaining
67% of variance (Table 1). Component 2 associated with KOOS pain and
ICOAP constant pain, not with VAS and ICOAP intermittent pain.
Component 3 associatedwithVASpain andnotwith other painmeasures.
Component 1 and 4 did not associate with any of the pain measures.
Conclusion: Different patterns of synovitis in knee OA were observed.
Results suggest that pain depends on synovitis pattern.17
HIGH SERUM-CHOLESTEROL LEVELS BY EITHER LOW DENSITY
LIPOPROTEIN RECEPTOR DEFICIENCY OR A CHOLESTEROL-RICH
DIET RESULTS IN SYNOVIAL ACTIVATION AND OSTEOPHYTE
FORMATION DURING EXPERIMENTAL OSTEOARTHRITIS
W. de Munter, A.W. Slöetjes, B. Walgreen, M.M. Helsen, W.B. van den
Berg, P.L. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
Netherlands
Purpose: Recently, we have shown that synovial activation plays an
important role in etiopathology of osteoarthritis (OA). Synovial
macrophages are involved in cartilage damage and are crucial for
osteophyte formation in experimental OAmodels. Increased cholesterol
levels have been correlated to OA pathology suggesting a metabolic
mechanism. Atherosclerotic studies show that scavenger receptors on
macrophages are capable of taking up oxidized low density lipoprotein
(oxLDL), resulting in increased inﬂammatory properties of the macro-
phage. Accumulated LDL can be oxidized in an inﬂammatory milieu
such as OA, possibly resulting in oxLDL uptake of synovial macrophages.
We investigated whether increased LDL levels could lead tomore severe
OA pathology in experimental induced OA.
Methods: LDL receptor deﬁcient (LDLr-/-) mice and their wild type (WT)
controls received either a cholesterol-rich or control diet for 120 days
(n¼10 mice per group). Experimental OAwas induced by intra-articular
injection of collagenase on day 84 and 86. 36 days after OA induction,
mice were sacriﬁced and total knee joints (for histological analysis) and
serum were collected. Cartilage damage, synovial thickening and
